SCP Vitalife seeks to invest in early- to mid-stage stage life science companies with exceptional technology or other proprietary advantages that are poised to capitalize on major market trends.
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Review
By reading these reviews and ratings, you agree to Tech in Asia’s terms of use.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar investors
Tired of ads? Enjoy an ad-free experience by signing up.